Page last updated: 2024-10-26

diclofenac and Signet Ring Cell Carcinoma

diclofenac has been researched along with Signet Ring Cell Carcinoma in 1 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Research Excerpts

ExcerptRelevanceReference
"Gastric cancer has one of the highest incidence rates of cancer worldwide while also contributing to increased drug resistance among patients in clinical practice."1.72Diclofenac Sensitizes Signet Ring Cell Gastric Carcinoma Cells to Cisplatin by Activating Autophagy and Inhibition of Survival Signal Pathways. ( Dejkriengkraikul, P; Lae Lae Phoo, N; Sukhamwang, A; Yodkeeree, S, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lae Lae Phoo, N1
Sukhamwang, A1
Dejkriengkraikul, P1
Yodkeeree, S1

Other Studies

1 other study available for diclofenac and Signet Ring Cell Carcinoma

ArticleYear
Diclofenac Sensitizes Signet Ring Cell Gastric Carcinoma Cells to Cisplatin by Activating Autophagy and Inhibition of Survival Signal Pathways.
    International journal of molecular sciences, 2022, Oct-11, Volume: 23, Issue:20

    Topics: Antioxidants; Apoptosis; Autophagy; Carcinoma, Signet Ring Cell; Cisplatin; Cyclin D1; Diclofenac; D

2022